Description
Ingredients in Palmetto Plus have been clinically researched to or may assist in:
- Management of medically diagnosed, benign prostatic hypertrophy (BPH).
- Reduce lower urinary tract symptoms associated with medically diagnosed BPH.
- Clinically researched Saw Palmetto and Nettle at a once daily dose.
Clinical benefits:
- Saw Palmetto may assist with the management of medically diagnosed BPH by acting as an inhibitor of 5-alpha-reductase.
- This is the primary mechanism by which Saw Palmetto relieves the symptoms of medically diagnosed benign prostatic hypertrophy.
- The combination of Saw Palmetto and Nettle have been shown to reduce specific lower urinary tract symptoms associated with medically diagnosed BPH, including urinary frequency, nocturnal urination, decreased urinary flow, hesitation and irritation, dribbling and incomplete emptying.
|
Each capsule contains: |
|
|
Extracts equivalent to: |
|
|
Trifolium pratense, herb top flowering fresh (Red clover) |
24.0 g |
|
Standardised to contain isoflavones (of Trifolium pratense) |
60 mg |
|
Serenoa repens, fruit dry (Saw palmetto) |
3.2 g |
|
Standardised to contain fatty acids |
288 mg |
|
Urtica dioica, root dry (Nettle) |
2.4 g |
|
Zinc amino acid chelate (Meta Zn® – Zinc bisglycinate) |
120 mg |
|
Equivalent Zinc |
24 mg |
Free from dairy protein, eggs, gluten, wheat, nuts, yeast and salt. Free from artificial colours and flavours.
- Always read the label. Follow the directions for use.
- If symptoms persist, consult your healthcare professional.
TGA Listed product with Aust L 194239.
Download TGA Public Summary for TGA published information including excipients, which are listed under 'Other Ingredients'.